|
Device Problems
Material Puncture/Hole (1504); Unexpected Therapeutic Results (1631)
|
Patient Problems
Stenosis (2263); Thrombosis/Thrombus (4440); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/11/2022 |
Event Type
Injury
|
Event Description
|
The following information was reported to gore: on an unknown date, in (b)(6) 2022, a gore® acuseal vascular graft was implanted for arteriovenous access.It was reported the patient initiated dialysis a day after the device was implanted.On (b)(6) 2022, the patient presented with outflow stenosis and thrombus accumulation at both venous and arterial ends of the graft.It was reported during angiographic evaluation, contrast was observed exiting through multiple cannulation needle holes in the center of the graft.The physician decided to abandon the graft and implant another vascular graft.The gore® acuseal vascular graft remains implanted.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Manufacturer Narrative
|
Added g3/g4: pma/510(k)number.Added h1/h2 and h6.Additional manufacturer narrative: cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Search Alerts/Recalls
|
|
|